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Ganoderma lucidum triterpenoids (GLT) possess advantageous characteristics including anti-
inflammatory, anti-oxidant and anti-cancer properties. In this study, a drug loaded core-shell fibrous 
system was engineered using the coaxial electrospinning method. The core comprised polycaprolactone 
and GTL whilst the shell contained polyethylene oxide with anti-cancer drug methotrexate. The 
morphology and structure, chemical composition, biocompatibility and in vitro release profile of the 
encapsulated GLT was assessed. Scanning electron microscopy images showed cylindrical fibers were 
developed whilst fluorescence microscopy confirmed the successful formation of core-shell fibers. 
Increasing GLT concentration from 2 wt% to 6 wt% resulted in an increase in mean fiber diameter from 
2.29 ± 1.26 µm to 4.65 ± 2.30 µm, respectively. Fourier transform infrared spectroscopy, X-ray 
diffraction and differential scanning calorimetry analysis all confirmed that both drugs were 
encapsulated in amorphous form while contact angle hysteresis showed engineered fibres to possess 
good hydrophilicity. In vitro drug release tests indicated the release of methotrexate (R2 = 0.9941) and 
GLT (R2 = 0.9924) were controlled by Fick Diffusion. In vitro cell culture experiments proved that the 
combined use of traditional Chinese medicine and current western medicine has good application 
prospects in the treatment of cervical cancer.  
 


















Ganoderma lucidum is a polypore fungus part of the Ganodermataceae family. It has been used for 
many years as a functional food and a medicine to promote health and longevity in the Asian 
community[1]. Ganoderma lucidum triterpenoids (GLT) are thought to be the reason as to why this 
fungus has a long history of effectiveness. GLT are the main component of Ganoderma lucidum spore 
powder (GLSP); the spores of G. lucidum[2]. GLT have shown a wide range of advantageous properties 
and have shown positive effects in anti-cancer therapy[3], anti-inflammation[4], anti-oxidation[5] and 
anti-proliferation[6]. The study results indicated that there was no obvious detectable toxicity for the 
GLT, even at a high dosage 5000 mg of GLT in mice per kg [7]. Despite these valuable applications, 
the use of these compounds is limited as they can be easily oxidised and the process of industrial 
extraction can prove difficult. As a result, it is necessary to explore the composition and biological 
activity of triterpenoids present in GLSP which may optimize and develop triterpenoid-based products.  
Electrospinning is a branch of electrohydrodynamic atomisation (EHDA) which enables the controlled 
engineering of single or multi-layered fibers on the micro and nanoscale. The fundamental principles 
of this technology involve introducing a voltage to a highly viscous formulation which is being fed 
through a conductive processing needle. Due to the presence of various forces acting on the solution 
(i.e. surface tension, gravity, electrostatic repulsion), the formulation exits the processing needle in the 
form of a “Taylor Cone” and due to high viscosity values, the solution is stretched from the needle 
exit[8].  This stretching of the solution enables the highly volatile solvent used to prepare the solution 
to evaporate; resulting in three-dimensional polymeric fibers. These structures have gained extensive 
attention in a multitude of applications ranging from tissue regeneration, diagnostics and 
pharmaceutical drug delivery[9-11]. 
Various developments to this basic set-up have been successful in recent years; the most common being 
coaxial electrospinning. Here, multi-layered fibers can be engineered by feeding two separate 
immiscible polymeric solutions through coaxially arranged conductive processing needles; resulting in 
core-shell fibers. The obtained fibers have excellent properties including high porosity and large surface 
area to volume ratio[12]. A range of materials can be utilized with this technology. Organic materials 
(including polymers) are dissolved in appropriate solvents to form homogeneous solutions without 
degradation [13]. The most critical advantage of these core-shell fibers is ability to load multiple drugs 
into the core and shell layers in a single-step process. Dual drug delivery is a sought-after application 
is easily achievable with coaxial electrospinning whilst also yielding fibers capable of possessing 
adequate morphology, hydrophobicity and mechanical properties[14].   
The main function of the polymer in the formation of coaxially developed fibers is to act as a carrier 
and to provide controlled release of the encapsulated drugs. The polymer can also be used to protect 
vulnerable or toxic ingredients. Polycaprolactone (PCL) is synthetic, biodegradable aliphatic 
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polyester[15] which has been proven to be biocompatible and is easily modified to develop structure of 
various morphologies[16, 17]. PCL has been broadly studied as a biopolymer and has found to be of 
extensive use in drug delivery systems, tissue engineering[16] and in particular wound dressings[15]. 
Polyethylene oxide (PEO) is also a biodegradable polymer with good biocompatibility. It is most 
commonly used as a matrix in drug delivery[18]. It is common knowledge that by amalgamating 
hydrophilic and hydrophobic polymers, the resulting polymeric mixture can possess improved 
mechanical strength and thermal stability[19]. Hence, here PCL (hydrophobic) and PEO (water-soluble) 
were used in combination.  
Methotrexate (2,4-diamino-N10-methylpropylglutamic acid, MTX) is a folic acid antimetabolite which 
has found to be useful in the treatment of solid tumor, haematological malignancies and autoimmune 
diseases[20]. In current cancer therapeutics, MTX plays an important role in the treatment of breast 
cancer, lung cancer, non-Hodgkin’s lymphoma, osteosarcoma and cervical cancer[21]. The latter is the 
second most common malignancy in women globally[22] hence it is critical to develop synergistic 
strategies in cancer treatment using surgery, chemotherapy and radiation therapy.  
As highlighted earlier, despite the prominent effects and reduced side effects of GLT products in 
preventative care and therapeutics, the content of GLT in GLSP is very limited and its extraction can 
also prove to be difficult due to elevated process parameters (i.e. temperature). GLT extraction is also 
a time-consuming process[23]. The oxidation of GLT in air also limits the practical application of the 
active. Therefore, it is necessary to protect the extracted component during processing and delivery. By 
developing an efficient coating method for GLT, the application potential of the active substance will 
be greatly improved. In the present study, coaxial electrospinning was utilised to develop core-shell 
dual drug loaded fibers. The coaxial electrospun fiber membrane (CESFM) was loaded with MTX and 
GLT. PEO formed the shell and PCL formed the core layer. This core-shell structure was used to control 
the drug release and maximise GLT potential. In addition, properties of the fabricated fibers such as 
morphology, physical and mechanical properties were characterised. Furthermore, the drug coating 
effect and release kinetics of the two drugs were explored and evaluated. Finally, the inhibitory effect 
of the CESFM on cervical cancer cells were examined.  
2 Materials and Methods 
2.1 Materials 
GLSP was obtained from Tianhe Agriculture Group (Zhejiang, China). The product met the 
requirements of GB7069 and was preserved at -4°C in complete darkness until any experimentation. 
Polycaprolactone (PCL) (Mw = 8 x 104 g/mol) was purchased from Sigma-Aldrich, St Louis, USA. 
Polyethylene oxide (PEO) (Mw = 9.0 × 105 g/mol) was obtained from Huagao Fine Chemical Co., Ltd. 
China. Methotrexate (MTX) was purchased from Nanjing Dulai Biotechnology Co., Ltd. (Nanjing, 
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China). Glacial acetic acid, absolute ethyl alcohol and phosphate buffer saline (PBS, pH = 7.4) were 
supplied by Sinopharm Chemical Reagent (China). Dulbecco's modified eagle medium (DMEM) was 
supplied by Gibco, Carlsbad, California, USA. Fetal bovine serum (FBS) was obtained from Sijiqin, 
Hangzhou, China. Deionized water (DI) was obtained from ultrapure water purifier (Millipore Milli-Q, 
Bedford, USA).  GLT was extracted from GLSP using ultrasonic extraction, and the obtained extract 
was concentrated in a rotary evaporator, then lyophilized and stored at 4°C for further analysis[23]. All 
chemicals and reagents used were of analytical grade.  
2.2 Preparation of electrospinning solutions  
A 20 wt% PCL solution was prepared by dissolved 5.25 g of PCL in 20 mL of glacial acetic acid. PEO 
solution was prepared by dissolving 0.3 g PEO in 10 mL aqueous solution of ethanol. Different 
concentrations of GLT (2 wt%, 4wt% and 6 wt%) was prepared by dissolving in glacial acetic acid and 
introducing this to the initial base PCL solution. 1 wt% MTX is added to the PEO solution to prepare 
the polymeric-drug solution. To obtain a homogenous, uniform solution, the suspension was 
continuously mixed at 300rpm using a magnetic stirrer for 12 hours at room temperature (25°C).  
2.3 PEO-MTX / PCL-GLT Fiber Fabrication  
The experimental set up for coaxial electrospinning technology is shown in Fig. 1a. The experimental 
set-up consists of a high voltage power supply (0 ~ 30kv, Glassman High Voltage Inc, USA), 2 syringe 
pumps (KD Scientific KDS100, USA) and a roller collector. The coaxially arranged processing needle 
comprised of an inner and outer needle. The inner/outer diameter of the inner and outer needle were 
0.2/0.4mm and 0.9/1.2mm, respectively.  
The core formulation (PCL-GLT) was fed through the inner needle at flow rates 0.5-0.8 mL/h whilst 
the shell formulation (PEO-MTX) was fed through the outer needle at a flow rate between 0.25 and 0.4 
mL/h. A roller collector (diameter: 7cm, length: 14 cm) was placed under the coaxial processing needle 
with a rotating speed of 1000-1400 rpm to collect the fabricated electrospun fibers. the vertical working 
distance between the needle exit and the roller was approximately 12 cm.  To show the formation of 
stable Taylor Cone jet, a preliminary electrospinning study was performed with a PCL-Rhodamine B 
solution being fed through the inner needle.  All experiments were performed at the ambient temperature 
(25°C). 
2.4 Fiber Morphology Assessment 
Optical Microscopy (OM, Phoenix BMC 503-ICCF, China), and Scanning Electron Microscopy (SEM, 
SEM, SU 8000 SEM, Hitachi, Japan) was utilised to examine the distribution and surface morphology 
of the resulting fibers. Before subjecting the fibrous structures to SEM analysis, the samples were 
mounted on a metal stub and were gold-coated under vacuum at a current intensity of 15 mA for 60 
seconds. Fiber diameter analysis was performed on electron micrographs using Image J software 
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(National Institute of Health, MD, USA). 100 random fibers were selected from each sample were 
calculated and plotted to decipher average fiber diameter. All statistical plots were drawn using Origin 
2017 (OriginLab, USA).  
2.5 Fourier transform infrared (FTIR) spectroscopy 
To study excipient and fiber stability, the composition and intermolecular interactions of CESFM was 
analysed using an FTIR spectrometer (IR Affinity 1, Shimadzu, Japan). Samples were prepared using 
the KBr pellet method. Approximately 2 mg of sample was mixed with approximately 200 mg KBr 
powder. The mixture was ground into a fine powder and was subsequently pressed into a transparent 
sheet using 20 MPa of pressure using a powder compressor (FW-4A, Tianjin TUOPU instrument Co 
Ltd, Tianjin, China). The samples were scanned within the FTIR spectrum of 4000 to 400 cm-1 at a 
resolution of 4 cm-1 and from 20 scans.  
2.6 X-Ray Diffraction (XRD) 
An X-Ray diffractometer (Gemini A OHra, Oxford Varian, UK) was used to analyse the crystal 
configuration of the CESFM at room temperature (25°C). The voltage and current were kept at 40 kV 
and 30 mA, respectively. The sample was scanned over a range from 3° to 60°over 2θ with step a change 
of 0.02°. 
2.7 Differential Scanning Calorimetry (DSC) 
DSC was utilised to study the thermal stability of the electrospun fibrous structures. A calorimeter (PE 
DSC 7, Perkin-Elmer, USA) was used. Sealed pans containing approximately 3 mg of the sample were 
heated under a flow of nitrogen gas at a rate of 30 °C/min from 30 to 400 °C. 
2.8 Contact Angle Analysis 
The contact angle (CA) between a water droplet and a material/sample will elude to the degree of 
hydrophilicity of the test sample[24]. Here, a contact angle goniometer (SL2000KB, Kino Industry Co, 
Ltd, USA) was used to study the hydrophilic properties of the CESFM. 1 µL water droplet is introduced 
to a glass slide on which the sample has been anchored too. The CA between the droplet and the sample 
is recorded for the first 10 sections following the introduction of the droplet. The experiment was carried 
out in drop mode at ambient temperatures. The experiment was repeated 5 times and an average was 
calculated.  
2.9 Release of MTX and GLT from the coaxial fibers 
2.9.1 MTX Release  
To assess the in vitro release of MTX, the sample was immersed in a glass vial containing 10 mL 
phosphate buffer saline (PBS, pH = 7.4) and this was placed into a gas bath thermostatic shaker (100 
rpm) (DDHZ-300, Suzhou Peiying Experimental Equipment Co, Ltd, Suzhou, China) at 37 °C. The 
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masses of samples with triterpenoids content of 2 wt%, 4 wt%, and 6 wt% were 4.14 ± 0.036, 6.63 ± 
0.012, and 6.36 ± 0.045 mg, respectively. At predetermined time points, 4 mL of sample release medium 
was removed and replaced with fresh medium. The removed samples were analysed using UV 
spectrophotometry (UV-2600 spectrophotometer, Shimadzu, Japan) at a wavelength of 303 nm.  
2.9.2 GLT Release 
To assess the in vitro release of GLT, the sample was immersed in a glass vial and placed into a 
thermostatic shaker as above. At predetermined time points, 1 mL of the PBS release medium (pH =7.4) 
was removed and supplemented with 1 mL fresh PBS. The removed samples here were analysed using 
UV spectroscopy at a wavelength of 545 nm.   
2.9.3 Drug Release, Loading Capacity and Encapsulation Efficiency  
The release rate of the drugs was calculated using Equation 1:  
Drug	release	(%) = ./
.0
×100                                     (1) 
mt is the weight of the drug (MTX or GLT) released at time point t and ms is the sum of the weight of 
the drug released.  
The loading capacity (LC) and encapsulation efficiency (EE) of MTX and GLT were evaluated to assess 
the packaging effect of the coaxial electrospinning process[25]. LC and EE were calculated using 




x100%  (2) 
EE(%) = 678	9:9;<	=:>98>9	:?	9@A98@B8>:ACD	:@	E897:9@8F;98	A>	978	?AG8@D	(EH)
678:@89A=;<	9:9;<	;E:J>9	:?	9@A98@B8>:ACD	:@	E897:9@8F;98	(EH)		
x100%  (3) 
 
The release kinetics of each active was also evaluated; fitting the in vitro release data into various kinetic 
models (Zero-order, first-order, Higuchi and Korsmeyer-Peppas) to determine the mechanism of release 
of GLT and MTX in a simulated neutral environment (pH = 7.4). The model with the highest correlation 
coefficient (R2) was considered the best fit model.  
2.10 Inhibition of Cervical cancer cells (HeLa)  
Any potential anti-cancer effect of the fabricated CESFM on Hela cells were studied. The HeLa cells 
were cultured in Dulbecco’s modified Eagle’s medium (DMEM, Corning, USA) supplemented with 
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10% fetal bovine serum (FBS, Gibco) and 1% Antibiotics (penicillin 100 U/mL and streptomycin 100 
µg/ mL). The cells were cultured in a 5% CO2 incubator at 37 °C.  
The effect of the fabricated CESFEM on HeLa cell viability was also investigated using a CCK-8 assay. 
The formulations tested were: CESFEM containing 1 wt% MTX, CESFEM containing 1 wt% MTX 
and GLT concentrations of 2 wt%, 4 wt%, and 6 wt%. These four formulations were introduced to 
DMEM medium and were left to release for one week. Then 100 µL of Hela cells (logarithmic growth 
phase) were introduced into a 96-well plate, cultured for 24 hours to allow their attachment to walls. 
The original medium was removed, and the drug-containing medium was changed, and cultured for 24 
hours. After 24 hours, the previous medium was removed, the medium was mixed with the CCK-8 
solution at a ratio of 10: 1, and 100 µL of the mixture was added to each well, and the 96-well plate was 
cultured in an incubator. 
The samples from the well plate were analysed using absorbance microplate reader. The cell survival 
rate was calculated using Equation 4:  
Cell	survival	rate = PQRPS
PTRPS
×100                                   (4) 
 
As: experimental wells (cell-containing culture medium, CCK-8, drug) 
Ac: control well (cell-containing medium, CCK-8, drug) 
Ab: blank wells (cell-free and drug, CCK-8) 
 
To observe the effect of CESFM on the HeLa cells, Alexa Fluor 546 phalloidin (P) (Invitrogen, 
California, USA) and 4’,6’-diamidino-2 phenylindole hydrochloride (DAPI) were used to strain the 
cytoskeleton and nuclei of the cells, respectively. The cell suspension (1.1 x105 cells) were inoculated 
onto petri dish into which the CESFM samples with various drug concentrations were introduced. These 
petri dishes were then cultured in an incubator for 48 hours. The cells were then rinsed with PBS and 
4% paraformaldehyde was added. This mixture was then stirred for 60 minutes at 60 rpm. 0.1% Triton 
was then introduced to the cells and this was stirred for a further 5 minutes at 60 rpm. The cells were 
then rinsed again 3 times with PBS and were subsequently stained with P (cytoskeleton for 20 mins) 
and DAPI (nuclei for 60 mins). The final stained cells were then observed under a fluorescent 
microscope.  
2.11 Statistical Analysis 
	 9	
All experiments were performed in triplicate, with results being expressed as mean ± standard deviation. 
Statistical analysis was performed using Origin Pro 2017 and Excel 2016. The t-test was used to 
calculate the p value and p < 0.05 was considered significant. 
3 Results and Discussion  
3.1 Fabrication and Characterisation of PEO-MTX/PLC-GLT Fibers 
Here, coaxial electrospinning technology was utilised to engineer a fibrous membrane containing 
bioactive MTX and GLT. The physical liquid parameters (viscosity, density, electroconductivity) and 
electrospinning process parameters (flow rate, applied voltage, collection distance) greatly affect the 
spin ability of the formulation and the stability of the resulting fibers[13].  
In order to observe the inner and outer solution in jetting mode, Rhodamine B was introduced to the 
PCL solution. In Fig. 1b, before the voltage was applied, a droplet with a red inner core can be observed 
at the needle exit. The colour difference between the PCL core and PEO shell indicates the 
encapsulation of PCL. When the voltage was increased to 6 kV, gravitational and electrostatic forces 
causes the droplet to be stretch. Increasing the voltage to 11 kV, the liquid began to form a jet (Fig. 1c). 
Fig. 2 displays the fluorescence micrograph of the resulting core-shell fiber. It is clear to see two 
distinctive layers; with a red inner layer confirming the successful formation of core-shell structure 
using coaxially arranged processing needles.  
3.2 Morphology of CESFM 
Fig. 3 shows the optical images (Fig. 3a1, b1, c1), electron micrographs (Fig. 3a2, b2, c2) and fiber 
diameter distribution (Fig. 3a3, b3 and c3) of the various CESFM samples. The optical images and 
SEM images show that all CESFM samples presented uniformly and well orientated fibers. The 
resulting structures presented a smooth surface morphology and cylindrical structures. As the 
concentration of triterpenoids increased, the fiber diameter increased and the fibers became more evenly 
distributed. The average diameter of electrospun fibers with GLT concentrations of 2 wt%, 4 wt% and 
6 wt% were 2.29 ± 1.26 µm, 3.30 ± 2.25 µm and 4.65 ± 2.30 µm, respectively. This increase in diameter 
may be due to increase in viscosity and decrease in conductivity as a result of increase in 
triterpenoids[26].  
3.3 FTIR Spectroscopy and XRD Analysis 
To evaluate and assess the composition and stability of the fiber matrices, FTIR spectroscopy was 
carried out. Fig. 4a shows the FTIR spectroscopy fingerprints of raw PCL, PEO, raw bioactive and the 
resulting engineered membrane. The strong peak at 2900 cm-1 in the FTIR spectra for pure PEO 
corresponds to the stretching mode of CH[27] while the peak at 1954 cm-1 corresponds to the 
asymmetric stretching of CH[28]. The peak at 1350 cm-1 is due to the swinging of the CH2 bond and 
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the peak at 1100 cm-1 is due to COC stretching[29]. The peaks at 960 cm-1 and 840 cm-1 corresponds to 
the CH2CH2 swing and CH2 swing, respectively[29]. The characteristic peaks at 2900 cm-1, 1800 cm-1 
and 1400 cm-1 which can be observed in the FTIR spectrum for PCL are due to the tensile vibrations of 
the C-H, CO and C-O bonds in PCL[30]. Pure MTX showed symmetrical and asymmetric tensile 
vibrations of COO- (νCOO-) at 1373 and 1554 cm-1, respectively[31]. The absorption peaks of 
triterpenoids in the spectrum are mainly at 1050 cm-1 (-OH group), 1740 cm-1 to 1760 cm-1 (five-
membered cyclic ketone), 1720 cm-1 (ester), 1710 cm-1 (six-membered ring) Ketone), 1650 cm-1 (α, β-
unsaturated ketone)[32].  In the spectrum of CEFSM the peak positions of triterpenoids changed. This 
is most likely due to the interaction between the compound molecules and it can also indicate that the 
drug was successfully encapsulated within the fiber matrix.  
XRD analysis was carried out to examine the crystal structures and physical changes (if any) of the 
drugs and polymers before and after electrohydrodynamic processing. It can be observed from the peaks 
in Figure 4b that the triterpenoids exist in amorphous form [33].	The peak seen between 2θ = 10° and 
30° for MTX is consistent with results found in literature [34]. Both polymers showed two distinct 
peaks: 2θ = 19.16° and 2θ = 23.34° for PEO[35] and 2θ = 21.38° and 2θ = 23.82° for PCL indicating 
the crystal properties of PCL[36]. No significant difference between the XRD patterns of the CESFM 
and the pure polymers highlighting the even distribution of both drugs. The existence of drugs in 
amorphous form shows desirable advantages including high solubility, fast dissolution rate, and easy 
absorption by the human body [37].  
3.4 Differential Scanning Calorimetry (DSC) Analysis 
The thermal behaviour of the materials and samples was assessed using DSC. Fig. 5 shows the resulting 
DSC thermograms.  A single endothermic peak can be observed in each of the thermograms for pure 
polymers and drugs. These peaks, seen at 69.7°C, 58 °C and 131.3°C for PEO, PCL and MTX, 
respectively, all correspond to melting points. It can be seen from the figure that the peak of triterpenoids 
was broad. The CESFM thermogram shows two endothermic peaks, which are the peaks of PCL and 
PEO. The absence of the strong endothermic peaks of MTX and triterpenoids in the CESFM 
thermogram proves the two drugs are present in the amorphous state in the electrospun fibers[38]. These 
DSC curves also highlight that fiber production and drug encapsulation here is successful at ambient 
temperatures; which is advantageous for thermo-sensitive/thermo-labile materials or actives.  
3.5 Contact Angle Hysteresis  
It is important to identify the hydrophilicity of a material as this can greatly affect biological application 
and drug release kinetics[39]. Fig. 6 shows the resulting surface hydrophilicity data collected from 
contact angle studies. The CA of each fibrous sample was measured from 0s to 10s. After 10 seconds 
the CA of each sample was recorded to be 7.25 ± 0.11, 7.83 ± 0.07, and 9.27 ± 0.18° for CESFM 
containing 2 wt%, 4 wt% and 6 wt% triterpenoids, respectively. These low values suggest the fibrous 
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membranes were hydrophilic. According to previous work in this field[40], PEO is a hydrophilic 
material and being the outer shell material of the bilayer fibers fabricated here, the low CA values were 
expected. The slight differences in CA are a result of the differences in GLT content.  Triterpenoids are 
polar compounds[41] hence the higher the concentration the higher the concentration of water 
molecules will prevent diffusion. When the triterpenoid concentration increased from 2 wt% to 6 wt% 
in 10 secs, there was no significant difference in the hydrophilicity of the CESFM. The size distribution 
and surface morphology of electrospun fibers are contribute to their hydrophilicity. The rough and 
uneven surface of the fiber will cause hydrophobicity[42].  As GLT concentration increased, the fiber 
diameter increases and surface becomes more rough resulting in decreased hydrophilicity.  
3.6 In Vitro Drug Release 
Compared to conventional encapsulation technologies such as dispersion and emulsification, coaxial 
electrospinning is more effective and economical for producing core-shell structures capable of 
achieving high LC and EE[43].  Fig. 7 shows the LC and EE that were calculated. The LC represents 
the mass of MTX or GLT coated per unit fiber mass. The EE is the ratio of the total drug mass added 
to the mass of drug effectively encapsulated in the fiber and the effectiveness of the coaxially arranged 
fibers. When triterpenoid concentration increased from 2 wt% to 6 wt%, the LC of MTX increased from 
0.63 ± 0.01% to 0.71 ± 0.01% and EE increased from 62.9 ± 0.5% to 72.1 ± 0.6% (Fig. 7a). GLT 
followed the same patterns (Fig. 7b). As concentration increased, triterpenoid LC increased from 0.20 
± 0.0013% to 0.72 ± 0.0042%. EE also increased from 9.77 ± 0.07% to 14.92 ± 0.070%. The ultimate 
conclusion from this study shows that triterpenoid concentration can improve LC and EE.  
In vitro drug release experiments were carried out using PBS solutions over 7 days. The experimental 
results can be seen in Fig. 8. In the first hour, the release of MTX from the CESFM containing 2 wt% 
GLT reached 75% whilst only 33% of GLT was release (Fig. 8a1). After 24 hours, MTX release was 
87% while triterpenoid release reached 73%. When GTL concentration was increased to 4 wt% (Fig. 
8b1) and 6 wt% (Fig. 8c1), no significant differences could be observed compared to concentration of 
2 wt%. This release study indicated that MTX was released in a biphasic manner; showing an initial 
burst release followed by a slower release phase. In contrast, the release of triterpenoids appeared to be 
much slower. This is most likely due to the fact that GLT was encapsulated in the inner core of the 
electrospun fibers. With PCL forming a large majority of this inner layer, the hydrophobicity of this 
layer contributes to the slow release of the encapsulated GLT[15]. The two different release profiles 
from MTX and GLT allows them to provide a good synergistic anti-cancer effect. Table 1 shows the 
resulting curves when the in vitro drug release data was fitted to various release kinetic models. As 
shown in Table 1, both bioactive showed release via Fick diffusion from the CESFM; proven by the 
high correlation coefficient that was demonstrated by Korsmeyer-Peppas model with a n value less than 
0.45.  
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3.7 Anti-Cancer effects on cervical cancer cells (HeLa)  
Previous literature in this field have shown that GLT possess advantageous anti-cancer effects[44]. This 
study was carried out to assess the effects of coaxially electrospun fibers encapsulation with 
triterpenoids and MTX on HeLa cells were studied. CCK-8 experiments were performed using HeLa 
cells. The experimental results are shown in Fig. 9. The cell survival rate of the fiber membrane loaded 
with only MTX. 79.90 ± 1.12% (in 24 hours). The cell survival rates were 72.89 ± 2.54 %, 70.28 ± 
2.05% and 67.42 ± 1.24%, for GLT concentrations 2 wt%, 4 wt% ad 6 wt%, respectively. The general 
trend saw that the higher the triterpenoids concentration, the more enhanced the anti-cancer effect. 
Moreover, when triterpenoid concentration was increased to 6 wt%, the cell survival rate decreased by 
12.48% compared to CESFM containing MTX only.  
Studies have shown that GLT extract inhibits the growth of HeLa cells by inhibiting the cell cycle and 
cell signal transduction by changing the calcium transport system[45]. Experiments have shown that 
GLT can directly and indirectly kill tumor cells whilst activating G0 tumor cells which are difficult to 
kill by chemotherapy drugs for separate and combined killing effects[46]. The unique effect of GLT on 
G0 phase cells and the effective suppression of recurrence and metastasis of malignant tumor make up 
for the deficiency of traditional tumor treatment (i.e. surgery, radiotherapy, chemotherapy) and become 
the main force in tumor immunotherapy. However, the experimental results demonstrate that the 
synergistic anticancer effect of MTX and GLT can pave a new combination for fiber based therapeutics. 
Fig. 10 shows a fluorescently stained image of the effect of CESFM on the morphology of HeLa cells. 
As seen in Fig. 10, the cells showed an irregular spindle-like morphology, and the morphology of the 
cells treated with the coaxial electrospun fiber membrane was not significantly different from the 
control (Fig. 10a1, a2). When treated with a fiber membrane containing only MTX (Fig. 10b1, b2), 
cell density becomes smaller, further indicating that the treatment group has a certain anti-cancer effect 
on the cells. The results are similar to those of the cell viability study when treated with fiber membranes 
with different concentrations of triterpenoids (2 wt%, 4 wt% and 6 wt%) (Fig. 10c1-e2). The cell density 
decreased significantly compared to the control, indicating that it had a significant inhibitory effect on 
the HeLa cells. Therefore, as an effective chemotherapy drug for human cervical cancer, the CESFM 
has broad prospects.  
4 Conclusion  
Core-shell drug-loaded fiber membranes were successfully prepared here via coaxial 
electrohydrodynamic spinning technology. MTX was encapsulated in PEO shell layer while GLT was 
loaded in the PCL core layer. Fluorescence microscopy confirmed the structure of the core-shell fibers 
and SEM analysis showed the resulting fibers were cylindrical in shape and had good alignment. FTIR 
spectroscopy, DSC and XRD showed that both drugs presented in amorphous form, were uniformly 
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dispersed and were successfully encapsulated within the polymer core-shell matrix. The in vitro release 
studies showed biphasic MTX release and slow GLT release. In vitro cell experiments showed both 
drugs had a synergistic effect on inhibitory effect of HeLa cells. The coaxial electrospinning method 
used here is a simple, easy to operate process which allows structures with controlled morphology to 
be fabricated whilst enabling the combination of Chinese and western medicine in single step for the 
treatment of cervical cancer.  
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Equation R2 Equation R2 
Zero order Rt=73.87+0.6923t 0.945 Rt=27.98+5.789t 0.9642 
First order lg(1-Rt)=-0.01217-0.5826t 0.9518 
lg(1-Rt)=-0.1375-
0.04299t 0.9799 
Higuchi Rt=72.69+1.924t0.5 0.9845 Rt=18.25+15.97t0.5 0.9902 
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Fig. 1. (a) Schematic diagram of the coaxial electrospinning set-up system, and digital images 
of the coaxial filament jet at applied voltage (b) 0 kV and (c) 11 kV.  
Fig. 2. The fluorescence microscope image of CESFM. (Inner layer was stained with 
Rhodamine B).  
Fig. 3. Optical micrographs (a1, b1, c1), scanning electron micrographs (a2, b2, c2) and 
diameter distribution diagrams (a3, b3, c3) of CESFM loaded with methotrexate and 
triterpenoids. The methotrexate concentration was 1wt% in all three samples, and triterpenoid 
concentration was a1-a3 2wt%; b1-b3: 4wt%; c1-c3: 6wt%.  
Fig. 4. (a) FTIR spectra and (b) XRD patterns of coaxial electrospun fiber membranes loaded 
with methotrexate and triterpenoids, raw polymer materials and pure drugs.  
Fig. 5. DSC curves of pure PEO, PCL, methotrexate, triterpenoids and coaxial electrospun 
fiber membranes (CESFM) loaded with methotrexate and triterpenoids. 
Fig. 6. Image of water contact angle of fiber membrane at different time points: 0 s, 5s and 10 
s. The three colours in the figure indicate three different samples, of which the triterpenoid 
content is 2wt%, 4wt%, and 6wt%, respectively. *p < 0.05, **p < 0.01, data represented as 
mean ± SD, n = 3. 
Fig. 7. Loading capacity and encapsulation efficiency of methotrexate (a) and triterpenoids (b) 
in CESFM. Samples refer to CESFM with triterpenoids contents of 2wt%, 4wt%, and 6wt%, 
respectively.	Data represented as mean ± SD, n =3. 
Fig. 8. Release kinetic curves of methotrexate and triterpenoids release from CESFM in PBS 
solution. a1, b1, c1: Release curve in the first 12 hours; a2, b2, c2: Release curve in the first 7 
days. a1, a2: triterpenoids’ concentration was 2 wt%; b1, b2: triterpenoids’ concentration was 
4 wt%; c1, c2: triterpenoids’ concentration was 6 wt%. Data represented as mean ± SD, n =3. 
Fig. 9. Effect of methotrexate and triterpenoids on cell viability of Hela Cells. *p < 0.05, 
**p < 0.01, data represented as mean ± SD, n = 7. Treatment with drugs for 24 hours.	 
Fig. 10. Fluorescence photomicrograph of HeLa cells (after adding CESFM, culture for 48 
hours). a1, a2: Control (untreated, no fiber membrane added); b1, b2: CESFM (1 wt% 
methotrexate); c1, c2: CESFM (1 wt% methotrexate, 2 wt% triterpenoids); d1, d2: CESFM (1 
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